NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...

Multiply Labs today announced an agreement with AstraZeneca to evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing. Multiply Labs is a current ...

Systemic inflammation has been elevated to a modifiable cardiovascular risk factor requiring assessment, monitoring, and modification, based on consensus recommendations.

The New England Patriots’ latest win was overshadowed by a worrying sight: star quarterback Drake Maye clutching his throwing ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that the U.S. Food and Drug Administration has granted orphan drug ...

The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary ...

Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with first-line therapies offering limited survival benefits despite advances ...

The princess visited Wakefield Trinity’s ground during a day spent in northern England.

In the spotlight are the following three breakthrough devices: CaviTONE™ LEGACY, FlowWave Focus™, and SmartPulse™ COOL ...

For one local teenager, everyday routines most of us take for granted — running errands, going to school, even watching a ...

The Princess of Wales has headed to Bradford today to visit a children's therapy service and will later visit a rain-soaked ...